Add time:07/11/2019         Source:sciencedirect.com

New analogues of the recently published compound DDD107498 were prepared. Their activities were examined in vitro against the chloroquine-sensitive NF54 strain. The most active were also tested against the multiresistant K1 strain of Plasmodium falciparum. A couple of the newly synthesized compounds showed promising antiplasmodial activity and selectivity. A single compound showed adequate reduction of parasitaemia (98.1%) in mice infected with Plasmodium berghei. Survival time was doubled compared to control. The results of the biological tests of the novel compounds were compared with the activities of drugs in use. Structure-activity relationships were discussed.

We also recommend Trading Suppliers and Manufacturers of 4-[(4-{4-nitrophenyl}-1-piperazinyl)carbonyl]-2-(3-methoxyphenyl)quinoline (cas 557781-33-6). Pls Click Website Link as below: cas 557781-33-6 suppliers